Last reviewed · How we verify
Dexketoprofen plus Morphine
At a glance
| Generic name | Dexketoprofen plus Morphine |
|---|---|
| Also known as | Arveles |
| Sponsor | Akdeniz University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparing the Safety and Effectiveness of Different Doses of Morphine Administered in Spinal Anethesia for Pain Relief After Hip Replacement Surgery (PHASE4)
- Intrathecal Morphine for Recovery and Outcomes After VATS (NA)
- Pectointercostal Fascial Plane Block Chronic Pain Sternotomy (NA)
- Evaluation of the Analgesic Efficacy of the Combination of Dexketoprofen + Paracetamol and the Combination of Naproxen Sodium + Codeine in Patients With Acute Dental Pain (PHASE4)
- Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair (PHASE4)
- The Postoperative Lidocaine and Ketamine Effects on Morphine Requirement in Bariatric Surgery
- Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery
- Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexketoprofen plus Morphine CI brief — competitive landscape report
- Dexketoprofen plus Morphine updates RSS · CI watch RSS
- Akdeniz University portfolio CI